Abstract

Maintenance of endothelial cell integrity is an important component of human health and disease since the endothelium can perform various functions including regulation of vascular tone, control of hemostasis and thrombosis, cellular adhesion, smooth muscle cell proliferation, and vascular inflammation. Endothelial dysfunction is encompassed by complex pathophysiology that is based on endothelial nitric oxide synthase uncoupling and endothelial activation following stimulation from various inflammatory mediators (molecular patterns, oxidized lipoproteins, cytokines). The downstream signaling via nuclear factor-κB leads to overexpression of adhesion molecules, selectins, and chemokines that facilitate leukocyte adhesion, rolling, and transmigration to the subendothelial space. Moreover, oscillatory shear stress leads to pro-inflammatory endothelial activation with increased monocyte adhesion and endothelial cell apoptosis, an effect that is dependent on multiple pathways and flow-sensitive microRNA regulation. Moreover, the role of neutrophil extracellular traps and NLRP3 inflammasome as inflammatory mechanisms contributing to endothelial dysfunction has recently been unveiled and is under further investigation. Consequently, and following their activation, injured endothelial cells release inflammatory mediators and enter a pro-thrombotic state through activation of coagulation pathways, downregulation of thrombomodulin, and an increase in platelet adhesion and aggregation owing to the action of von-Willebrand factor, ultimately promoting atherosclerosis progression.

Highlights

  • Cardiovascular diseases represent the primary cause of morbidity and mortality in western societies despite the breakthroughs in their diagnosis, treatment, and prevention.Several risk factors are implicated in their pathogenesis, such as arterial hypertension, diabetes mellitus (DM), smoking, and obesity

  • Endothelial dysfunction is the result of an imbalance between vasodilators and vasoconstrictors produced by endothelial cells, leading to an atheroprone phenotype consisting of vasoconstriction, leukocyte trafficking, inflammation, and coagulation-thrombosis

  • Lead to an imbalance of endothelial NOS (eNOS) and inducible NOS (iNOS) mediated by High-mobility group box 1 (HMGB1)toll-like receptor (TLR) pathway and lectin-type oxidized low-density lipoprotein (oxLDL) receptor 1 (LOX-1)-nuclear factorκB (NF-κB) pathway respectively, resulting in endothelial dysfunction due to endothelial cells (EC)

Read more

Summary

Introduction

Cardiovascular diseases represent the primary cause of morbidity and mortality in western societies despite the breakthroughs in their diagnosis, treatment, and prevention. Several risk factors are implicated in their pathogenesis, such as arterial hypertension, diabetes mellitus (DM), smoking, and obesity. Most of these processes are linked with endothelial dysfunction, the initial step of atherogenesis, which has been proven to be a precursor of adverse cardiovascular outcomes [1,2,3,4]. A lot of interest has been shown on the pro-inflammatory state stemming from the cluster of comorbidities frequently encompassing patients with cardiovascular diseases and its deleterious effect on atherosclerosis. In the context of this narrative review, we present the inflammatory mechanisms involved in the development of endothelial dysfunction and the potential therapeutic implications according to the latest preclinical and clinical studies.

Endothelial Cell Anatomy and Function
Regulation of Vascular Tone
The Role of Nitric Oxide
Assessment of Endothelial Function
Pathophysiology of Endothelial Dysfunction
Smoking
Diabetes Mellitus
Arterial Hypertension
Hypercholesterolemia
The Role of Inflammation in Endothelial Dysfunction
TLRs and Endothelial Dysfunction
NLRP3 Inflammasome and Endothelial Dysfunction
The Role of NF-κB and Adhesion Molecules
The Pro-Inflammatory Effect of NOX
Neutrophil Extracellular Traps
Shear Stress
Endothelial Dysfunction in Chronic Inflammatory Diseases
A Link between Inflammation and Thrombosis in Endothelial Dysfunction
Clinical Implications and Future Directions
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.